The Peptide Library

BPC-157

Animal Research

The Healer

Body Protection Compound-157

BPC-157 is a synthetic peptide derived from a protective protein naturally found in human gastric juice. It is one of the most discussed research peptides for tissue repair and gut health, though almost all of the published evidence to date comes from animal models.

Quick Answers

Is BPC-157 legal in 2026?

BPC-157 is not an FDA-approved drug. It was placed on the FDA's Category 2 bulk-substance list and is under regulatory review ahead of the 2026 PCAC hearings. It is sold for research purposes only, and its legal status is actively changing.

What does BPC-157 do?

In animal studies, BPC-157 has been researched for tissue repair — tendons, ligaments, muscle, and the gut lining — primarily through promoting new blood-vessel formation and modulating healing pathways.

How long does BPC-157 take to work?

There is no established human timeline because there are no large published human trials. Any timeframes you see online are anecdotal, not clinically validated.

Is BPC-157 safe?

Animal studies report a favorable short-term profile, but long-term human safety has not been established in published clinical trials. This is educational information based on published research — not medical advice. Always consult a qualified healthcare provider before considering any peptide.

How BPC-157 works

Research suggests BPC-157 promotes angiogenesis (the formation of new blood vessels) and modulates growth-factor and nitric-oxide pathways involved in healing. These mechanisms are proposed to support tendon, ligament, muscle, and gastrointestinal tissue repair in animal studies.

What the research says

The bulk of BPC-157 research consists of rodent studies from Sikirić and colleagues exploring tendon-to-bone healing, gut protection, and wound recovery. There are currently no large, published, peer-reviewed human clinical trials confirming these effects, so its profile in people remains unestablished.

Is BPC-157 legal in 2026?

Not FDA-approved for human use. BPC-157 was placed on the FDA's Category 2 bulk drug substances list (substances the agency identified as raising safety concerns for compounding), and it is among the peptides under review ahead of the 2026 Pharmacy Compounding Advisory Committee (PCAC) discussions. It is sold widely as a 'research chemical,' not as an approved medicine.

Last updated: June 2026

See the full Peptide Legal Status Tracker

Educational content only — not medical advice. Always consult a qualified healthcare provider before considering any peptide.